

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 7.64030605 |
| 2 | thrombin receptor signaling pathway (GO:0070493) | 6.91470797 |
| 3 | protein neddylation (GO:0045116) | 5.84240807 |
| 4 | regulation of platelet aggregation (GO:0090330) | 5.72105678 |
| 5 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.54469229 |
| 6 | positive regulation of mast cell activation (GO:0033005) | 5.53208578 |
| 7 | regulation of platelet activation (GO:0010543) | 5.27498767 |
| 8 | blood coagulation, intrinsic pathway (GO:0007597) | 4.85127998 |
| 9 | platelet aggregation (GO:0070527) | 4.83663886 |
| 10 | adenosine receptor signaling pathway (GO:0001973) | 4.82942676 |
| 11 | neutrophil activation (GO:0042119) | 4.79471163 |
| 12 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.49946139 |
| 13 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.45937186 |
| 14 | angiogenesis involved in wound healing (GO:0060055) | 4.37165681 |
| 15 | lipoxygenase pathway (GO:0019372) | 4.34511911 |
| 16 | granulocyte activation (GO:0036230) | 4.27367860 |
| 17 | negative regulation of norepinephrine secretion (GO:0010700) | 4.16011888 |
| 18 | megakaryocyte development (GO:0035855) | 4.12026463 |
| 19 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.07950755 |
| 20 | negative regulation of platelet activation (GO:0010544) | 4.04002637 |
| 21 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.02327940 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.91059694 |
| 23 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.88758493 |
| 24 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.78165293 |
| 25 | positive regulation of macrophage differentiation (GO:0045651) | 3.74953825 |
| 26 | regulation of mast cell activation (GO:0033003) | 3.70931898 |
| 27 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.69274734 |
| 28 | positive regulation of mast cell degranulation (GO:0043306) | 3.69274734 |
| 29 | regulation of integrin activation (GO:0033623) | 3.66408366 |
| 30 | regulation of lipoprotein metabolic process (GO:0050746) | 3.64370274 |
| 31 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.63377868 |
| 32 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.56823474 |
| 33 | platelet degranulation (GO:0002576) | 3.56759522 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.56747804 |
| 35 | homotypic cell-cell adhesion (GO:0034109) | 3.52194477 |
| 36 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.48916487 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 3.48880435 |
| 38 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.45834965 |
| 39 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.45834965 |
| 40 | platelet formation (GO:0030220) | 3.45661186 |
| 41 | cellular extravasation (GO:0045123) | 3.45284482 |
| 42 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.43408654 |
| 43 | platelet activation (GO:0030168) | 3.40295096 |
| 44 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.32455449 |
| 45 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.31987461 |
| 46 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.30329970 |
| 47 | regulation of regulatory T cell differentiation (GO:0045589) | 3.29974998 |
| 48 | positive regulation of blood coagulation (GO:0030194) | 3.29860134 |
| 49 | positive regulation of hemostasis (GO:1900048) | 3.29860134 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 3.27370884 |
| 51 | purinergic receptor signaling pathway (GO:0035587) | 3.26755912 |
| 52 | low-density lipoprotein particle remodeling (GO:0034374) | 3.24430317 |
| 53 | negative regulation of heart rate (GO:0010459) | 3.22063775 |
| 54 | positive regulation of receptor recycling (GO:0001921) | 3.21699056 |
| 55 | dendritic cell chemotaxis (GO:0002407) | 3.21023215 |
| 56 | leukocyte degranulation (GO:0043299) | 3.18397096 |
| 57 | positive regulation of B cell mediated immunity (GO:0002714) | 3.16461423 |
| 58 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.16461423 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.14316667 |
| 60 | phagocytosis, engulfment (GO:0006911) | 3.14230415 |
| 61 | microglial cell activation (GO:0001774) | 3.13544173 |
| 62 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.11296011 |
| 63 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.09111600 |
| 64 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.08401527 |
| 65 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.02546292 |
| 66 | positive regulation of coagulation (GO:0050820) | 3.01403882 |
| 67 | regulation of memory T cell differentiation (GO:0043380) | 2.98432873 |
| 68 | negative regulation of interleukin-17 production (GO:0032700) | 2.95969928 |
| 69 | B cell mediated immunity (GO:0019724) | 2.94186166 |
| 70 | polyamine biosynthetic process (GO:0006596) | 2.92328952 |
| 71 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.89825591 |
| 72 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.89141631 |
| 73 | positive regulation of granulocyte differentiation (GO:0030854) | 2.87532492 |
| 74 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.85991674 |
| 75 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.85058767 |
| 76 | negative regulation of cell killing (GO:0031342) | 2.85058767 |
| 77 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.84293972 |
| 78 | negative regulation of T cell apoptotic process (GO:0070233) | 2.83110142 |
| 79 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.82605722 |
| 80 | termination of signal transduction (GO:0023021) | 2.81378930 |
| 81 | autophagic vacuole fusion (GO:0000046) | 2.81066928 |
| 82 | negative regulation of protein localization to cell surface (GO:2000009) | 2.79306738 |
| 83 | dendritic cell migration (GO:0036336) | 2.79071310 |
| 84 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.78924578 |
| 85 | positive regulation of type 2 immune response (GO:0002830) | 2.78724359 |
| 86 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.78453668 |
| 87 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.77744168 |
| 88 | negative regulation of heart contraction (GO:0045822) | 2.74493164 |
| 89 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.74360806 |
| 90 | immunoglobulin mediated immune response (GO:0016064) | 2.72682788 |
| 91 | negative regulation of appetite (GO:0032099) | 2.72325831 |
| 92 | negative regulation of response to food (GO:0032096) | 2.72325831 |
| 93 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.71617843 |
| 94 | regulation of hemostasis (GO:1900046) | 2.71208234 |
| 95 | regulation of blood coagulation (GO:0030193) | 2.71208234 |
| 96 | peptide catabolic process (GO:0043171) | 2.69270324 |
| 97 | regulation of leukocyte degranulation (GO:0043300) | 2.68962943 |
| 98 | regulation of norepinephrine secretion (GO:0014061) | 2.68610121 |
| 99 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.68423702 |
| 100 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.66630413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.17052625 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.06069580 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.71099649 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.59363725 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.53368654 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.51807873 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.02456955 |
| 8 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.81961039 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.77095564 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.74529616 |
| 11 | GATA1_19941826_ChIP-Seq_K562_Human | 2.74062409 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.73133964 |
| 13 | SPI1_23127762_ChIP-Seq_K562_Human | 2.69486608 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.66364319 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.64388503 |
| 16 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.57985653 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.53766896 |
| 18 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.50303551 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40241387 |
| 20 | GATA2_19941826_ChIP-Seq_K562_Human | 2.32360510 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.31974067 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31157769 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16315399 |
| 24 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.12301037 |
| 25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.08577130 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01169802 |
| 27 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.97005071 |
| 28 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.96142486 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.92920101 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.90730224 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89755796 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.82379832 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.72381987 |
| 34 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.66497383 |
| 35 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63875721 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.63305396 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61685255 |
| 38 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.58998114 |
| 39 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.54272043 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.53338143 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51923003 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48487084 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45589594 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.40227822 |
| 45 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38705845 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37546079 |
| 47 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36483795 |
| 48 | MYB_26560356_Chip-Seq_TH2_Human | 1.36409878 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27666326 |
| 50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.22743563 |
| 51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.21632511 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20905539 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19709217 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15840783 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13305683 |
| 56 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.12597060 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11836196 |
| 58 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11461848 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07952327 |
| 60 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07796169 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05432684 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04858122 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04089025 |
| 64 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.03372474 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01746479 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98598762 |
| 67 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97847672 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97400553 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97400553 |
| 70 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.96950699 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96948838 |
| 72 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96617745 |
| 73 | MYB_26560356_Chip-Seq_TH1_Human | 0.96132702 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93885430 |
| 75 | MAF_26560356_Chip-Seq_TH1_Human | 0.92503870 |
| 76 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.92085537 |
| 77 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.89707809 |
| 78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89093114 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86479907 |
| 80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85876403 |
| 81 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.82527938 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81684439 |
| 83 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80212608 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79734413 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79093656 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78647566 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78605360 |
| 88 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.76433645 |
| 89 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.75308994 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74477167 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.74464786 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72993296 |
| 93 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.72530153 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71019508 |
| 95 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.70645605 |
| 96 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.69500806 |
| 97 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.69331688 |
| 98 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68847587 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65577519 |
| 100 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.65397174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 8.39780364 |
| 2 | MP0008004_abnormal_stomach_pH | 5.00308489 |
| 3 | MP0003724_increased_susceptibility_to | 4.48438801 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.27387291 |
| 5 | MP0000465_gastrointestinal_hemorrhage | 3.26484646 |
| 6 | MP0004510_myositis | 3.21834235 |
| 7 | MP0003303_peritoneal_inflammation | 2.91690595 |
| 8 | MP0005671_abnormal_response_to | 2.80990816 |
| 9 | MP0000343_altered_response_to | 2.34288664 |
| 10 | MP0003436_decreased_susceptibility_to | 2.32209235 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.28665554 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.17353112 |
| 13 | MP0005083_abnormal_biliary_tract | 2.06788468 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.02730063 |
| 15 | MP0003566_abnormal_cell_adhesion | 1.96690770 |
| 16 | MP0003828_pulmonary_edema | 1.91600771 |
| 17 | MP0010155_abnormal_intestine_physiology | 1.87983208 |
| 18 | MP0001800_abnormal_humoral_immune | 1.80522842 |
| 19 | MP0002419_abnormal_innate_immunity | 1.80326187 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.80303777 |
| 21 | MP0002723_abnormal_immune_serum | 1.77634720 |
| 22 | MP0005387_immune_system_phenotype | 1.74145698 |
| 23 | MP0001790_abnormal_immune_system | 1.74145698 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.72914769 |
| 25 | MP0002398_abnormal_bone_marrow | 1.69045930 |
| 26 | MP0005025_abnormal_response_to | 1.68847191 |
| 27 | MP0004947_skin_inflammation | 1.66330570 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.61775958 |
| 29 | MP0000230_abnormal_systemic_arterial | 1.59682835 |
| 30 | MP0001851_eye_inflammation | 1.58821091 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.54923473 |
| 32 | MP0001819_abnormal_immune_cell | 1.54114522 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.50491356 |
| 34 | MP0003638_abnormal_response/metabolism_ | 1.42751049 |
| 35 | MP0000858_altered_metastatic_potential | 1.39955261 |
| 36 | MP0000685_abnormal_immune_system | 1.38974339 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.37412895 |
| 38 | MP0004130_abnormal_muscle_cell | 1.35647280 |
| 39 | MP0004036_abnormal_muscle_relaxation | 1.35463633 |
| 40 | MP0009764_decreased_sensitivity_to | 1.35411000 |
| 41 | MP0008775_abnormal_heart_ventricle | 1.34828470 |
| 42 | MP0000249_abnormal_blood_vessel | 1.34684858 |
| 43 | MP0009785_altered_susceptibility_to | 1.34610443 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.32953541 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.32383067 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.32275689 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.32275689 |
| 48 | MP0002132_abnormal_respiratory_system | 1.31345222 |
| 49 | MP0001663_abnormal_digestive_system | 1.30334551 |
| 50 | MP0002736_abnormal_nociception_after | 1.30070043 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.29623338 |
| 52 | MP0009763_increased_sensitivity_to | 1.28974853 |
| 53 | MP0000716_abnormal_immune_system | 1.26649588 |
| 54 | MP0002429_abnormal_blood_cell | 1.24993011 |
| 55 | MP0003866_abnormal_defecation | 1.22900474 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.19623291 |
| 57 | MP0003879_abnormal_hair_cell | 1.16677349 |
| 58 | MP0002722_abnormal_immune_system | 1.16363431 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.16208277 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.15716590 |
| 61 | MP0010329_abnormal_lipoprotein_level | 1.08887191 |
| 62 | MP0008872_abnormal_physiological_respon | 1.06332961 |
| 63 | MP0006082_CNS_inflammation | 1.05153548 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.02570475 |
| 65 | MP0003075_altered_response_to | 1.02270356 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.01917621 |
| 67 | MP0008874_decreased_physiological_sensi | 1.01709865 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.00824929 |
| 69 | MP0002405_respiratory_system_inflammati | 1.00772504 |
| 70 | MP0004883_abnormal_blood_vessel | 1.00066445 |
| 71 | MP0005410_abnormal_fertilization | 0.98878231 |
| 72 | MP0003448_altered_tumor_morphology | 0.95360393 |
| 73 | MP0009765_abnormal_xenobiotic_induced | 0.93843224 |
| 74 | MP0006054_spinal_hemorrhage | 0.88884178 |
| 75 | MP0005174_abnormal_tail_pigmentation | 0.87439103 |
| 76 | MP0005409_darkened_coat_color | 0.87308025 |
| 77 | MP0009642_abnormal_blood_homeostasis | 0.84994173 |
| 78 | MP0003763_abnormal_thymus_physiology | 0.83975925 |
| 79 | MP0001879_abnormal_lymphatic_vessel | 0.80878603 |
| 80 | MP0000703_abnormal_thymus_morphology | 0.80248490 |
| 81 | MP0002733_abnormal_thermal_nociception | 0.80094587 |
| 82 | MP0005381_digestive/alimentary_phenotyp | 0.77799052 |
| 83 | MP0004484_altered_response_of | 0.77764064 |
| 84 | MP0003091_abnormal_cell_migration | 0.76313929 |
| 85 | MP0005023_abnormal_wound_healing | 0.75945821 |
| 86 | MP0008260_abnormal_autophagy | 0.75126208 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.74498025 |
| 88 | MP0005165_increased_susceptibility_to | 0.73031405 |
| 89 | MP0005166_decreased_susceptibility_to | 0.72291545 |
| 90 | MP0001968_abnormal_touch/_nociception | 0.70655542 |
| 91 | MP0008469_abnormal_protein_level | 0.69720667 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.69622117 |
| 93 | MP0005365_abnormal_bile_salt | 0.69021664 |
| 94 | MP0000490_abnormal_crypts_of | 0.67440149 |
| 95 | MP0001664_abnormal_digestion | 0.65370895 |
| 96 | MP0002118_abnormal_lipid_homeostasis | 0.63886122 |
| 97 | MP0005310_abnormal_salivary_gland | 0.63721005 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.61810669 |
| 99 | MP0004381_abnormal_hair_follicle | 0.61750632 |
| 100 | MP0005646_abnormal_pituitary_gland | 0.60833444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 9.89985783 |
| 2 | Menorrhagia (HP:0000132) | 9.79490906 |
| 3 | Petechiae (HP:0000967) | 9.51017403 |
| 4 | Abnormal platelet volume (HP:0011876) | 9.50025322 |
| 5 | Purpura (HP:0000979) | 8.78376721 |
| 6 | Epistaxis (HP:0000421) | 7.58133636 |
| 7 | Gingival bleeding (HP:0000225) | 7.11807070 |
| 8 | Abnormal platelet function (HP:0011869) | 5.66331698 |
| 9 | Impaired platelet aggregation (HP:0003540) | 5.66331698 |
| 10 | Spontaneous hematomas (HP:0007420) | 5.12088977 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.84473641 |
| 12 | Poikilocytosis (HP:0004447) | 3.83460810 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.70601553 |
| 14 | Acanthocytosis (HP:0001927) | 3.66387161 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 3.51866613 |
| 16 | Bruising susceptibility (HP:0000978) | 3.47128655 |
| 17 | Dyschromatopsia (HP:0007641) | 3.34423432 |
| 18 | Conjunctival telangiectasia (HP:0000524) | 3.21723326 |
| 19 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.92095458 |
| 20 | Eczematoid dermatitis (HP:0000976) | 2.90184150 |
| 21 | Abnormal pupillary function (HP:0007686) | 2.86190203 |
| 22 | Stomatitis (HP:0010280) | 2.84936242 |
| 23 | Increased density of long bones (HP:0006392) | 2.83472516 |
| 24 | Recurrent abscess formation (HP:0002722) | 2.79772047 |
| 25 | Recurrent bacterial skin infections (HP:0005406) | 2.78614817 |
| 26 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.71558336 |
| 27 | Joint hemorrhage (HP:0005261) | 2.68006091 |
| 28 | Hepatosplenomegaly (HP:0001433) | 2.67722601 |
| 29 | Paralysis (HP:0003470) | 2.61175475 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58205419 |
| 31 | Obstructive lung disease (HP:0006536) | 2.58205419 |
| 32 | Encephalitis (HP:0002383) | 2.44908121 |
| 33 | Abnormality of lateral ventricle (HP:0030047) | 2.44543012 |
| 34 | Joint swelling (HP:0001386) | 2.44212229 |
| 35 | Increased IgM level (HP:0003496) | 2.43606771 |
| 36 | Arterial thrombosis (HP:0004420) | 2.43464704 |
| 37 | Chest pain (HP:0100749) | 2.26957272 |
| 38 | Abnormality of iron homeostasis (HP:0011031) | 2.21661224 |
| 39 | Tinnitus (HP:0000360) | 2.17479464 |
| 40 | Abnormal auditory evoked potentials (HP:0006958) | 2.13177359 |
| 41 | Xanthomatosis (HP:0000991) | 2.11480747 |
| 42 | Upper limb muscle weakness (HP:0003484) | 2.02568179 |
| 43 | Prolonged bleeding time (HP:0003010) | 10.9350467 |
| 44 | Episodic fever (HP:0001954) | 1.98927941 |
| 45 | Spontaneous abortion (HP:0005268) | 1.98348398 |
| 46 | Thrombocytosis (HP:0001894) | 1.97107758 |
| 47 | Vertigo (HP:0002321) | 1.95098876 |
| 48 | Myocardial infarction (HP:0001658) | 1.94370672 |
| 49 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92026881 |
| 50 | Ventricular fibrillation (HP:0001663) | 1.91979803 |
| 51 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88317823 |
| 52 | Dysostosis multiplex (HP:0000943) | 1.88293125 |
| 53 | Inflammation of the large intestine (HP:0002037) | 1.87833739 |
| 54 | Increased serum ferritin (HP:0003281) | 1.87506438 |
| 55 | Polycythemia (HP:0001901) | 1.87271069 |
| 56 | Autoimmune hemolytic anemia (HP:0001890) | 1.83074092 |
| 57 | Decreased central vision (HP:0007663) | 1.83055083 |
| 58 | Abnormality of the prostate (HP:0008775) | 1.82123731 |
| 59 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.81423516 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 1.81372398 |
| 61 | Basal ganglia calcification (HP:0002135) | 1.80668453 |
| 62 | Amaurosis fugax (HP:0100576) | 1.79525344 |
| 63 | Leukocytosis (HP:0001974) | 1.79000903 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 1.77791635 |
| 65 | Vasculitis (HP:0002633) | 1.76709677 |
| 66 | Meningitis (HP:0001287) | 1.75402659 |
| 67 | Recurrent fungal infections (HP:0002841) | 1.74555031 |
| 68 | Thrombophlebitis (HP:0004418) | 1.74149209 |
| 69 | Retrobulbar optic neuritis (HP:0100654) | 1.72939418 |
| 70 | Optic neuritis (HP:0100653) | 1.72939418 |
| 71 | Nausea (HP:0002018) | 1.72663840 |
| 72 | Distal lower limb amyotrophy (HP:0008944) | 1.72344171 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 1.71039972 |
| 74 | Myositis (HP:0100614) | 1.67645532 |
| 75 | Papillary thyroid carcinoma (HP:0002895) | 1.67619531 |
| 76 | Recurrent skin infections (HP:0001581) | 1.67462947 |
| 77 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.66444871 |
| 78 | Pulmonary embolism (HP:0002204) | 1.65940953 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.65608480 |
| 80 | Orchitis (HP:0100796) | 1.62047093 |
| 81 | Muscle fibrillation (HP:0010546) | 1.57778336 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 1.57523563 |
| 83 | Mucosal telangiectasiae (HP:0100579) | 1.56706000 |
| 84 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.56265498 |
| 85 | Male infertility (HP:0003251) | 1.54815643 |
| 86 | Cerebral ischemia (HP:0002637) | 1.53744625 |
| 87 | Diplopia (HP:0000651) | 1.53006179 |
| 88 | Abnormality of binocular vision (HP:0011514) | 1.53006179 |
| 89 | Gastrointestinal infarctions (HP:0005244) | 1.51894523 |
| 90 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.51832495 |
| 91 | T lymphocytopenia (HP:0005403) | 1.51605774 |
| 92 | Generalized aminoaciduria (HP:0002909) | 1.50408695 |
| 93 | Uterine leiomyosarcoma (HP:0002891) | 1.48560821 |
| 94 | Leiomyosarcoma (HP:0100243) | 1.48560821 |
| 95 | Chronic otitis media (HP:0000389) | 1.48490741 |
| 96 | Arthralgia (HP:0002829) | 1.48150865 |
| 97 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.46833267 |
| 98 | Recurrent cutaneous fungal infections (HP:0011370) | 1.46305391 |
| 99 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.46305391 |
| 100 | Abnormality of T cell number (HP:0011839) | 1.45626632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 6.20119554 |
| 2 | MST4 | 3.85275038 |
| 3 | BMX | 3.51681959 |
| 4 | TEC | 3.10566911 |
| 5 | BTK | 2.89560109 |
| 6 | MYLK | 2.75238597 |
| 7 | BLK | 2.62962792 |
| 8 | SYK | 2.57923308 |
| 9 | CSF1R | 2.48083467 |
| 10 | EIF2AK1 | 2.47446721 |
| 11 | PTK2B | 2.34829074 |
| 12 | PIK3CG | 2.31091245 |
| 13 | ZAP70 | 2.30869565 |
| 14 | TAOK3 | 2.23505158 |
| 15 | BMPR2 | 2.10026205 |
| 16 | FGR | 1.99525466 |
| 17 | GRK6 | 1.92995333 |
| 18 | HCK | 1.77018201 |
| 19 | FES | 1.70006806 |
| 20 | GRK5 | 1.65140999 |
| 21 | CSK | 1.54555279 |
| 22 | MAP2K3 | 1.49757192 |
| 23 | STK3 | 1.41895576 |
| 24 | LYN | 1.38296676 |
| 25 | TNK2 | 1.37664574 |
| 26 | MAP4K1 | 1.36742405 |
| 27 | TXK | 1.32892943 |
| 28 | ILK | 1.21380184 |
| 29 | ADRBK2 | 1.19839213 |
| 30 | ITK | 1.19322048 |
| 31 | JAK3 | 1.12553575 |
| 32 | IKBKB | 1.11610136 |
| 33 | PDK1 | 1.09274678 |
| 34 | STK24 | 1.09060063 |
| 35 | PDPK1 | 1.04531797 |
| 36 | MATK | 1.04273228 |
| 37 | ACVR1B | 1.03956532 |
| 38 | IRAK1 | 0.97613565 |
| 39 | JAK1 | 0.96872823 |
| 40 | SIK3 | 0.96602012 |
| 41 | PAK1 | 0.92386955 |
| 42 | YES1 | 0.91525688 |
| 43 | TYK2 | 0.88423904 |
| 44 | TNIK | 0.86774164 |
| 45 | MAP3K5 | 0.86296304 |
| 46 | JAK2 | 0.86208684 |
| 47 | IRAK4 | 0.86100662 |
| 48 | LCK | 0.81554274 |
| 49 | PIM2 | 0.80083963 |
| 50 | EPHB1 | 0.79405726 |
| 51 | EPHA3 | 0.78649171 |
| 52 | MAP3K3 | 0.75405214 |
| 53 | TAOK1 | 0.74983491 |
| 54 | DAPK3 | 0.74623663 |
| 55 | ARAF | 0.72707533 |
| 56 | RET | 0.71650640 |
| 57 | MAPKAPK3 | 0.71101858 |
| 58 | LMTK2 | 0.69103500 |
| 59 | MARK3 | 0.67526483 |
| 60 | PNCK | 0.66650057 |
| 61 | ERBB2 | 0.63204023 |
| 62 | FYN | 0.63024734 |
| 63 | ADRBK1 | 0.62843942 |
| 64 | PRKD1 | 0.61233055 |
| 65 | TAOK2 | 0.59482103 |
| 66 | MAPK12 | 0.59070822 |
| 67 | CAMKK2 | 0.58684442 |
| 68 | STK4 | 0.58473069 |
| 69 | DAPK2 | 0.57132278 |
| 70 | PDGFRB | 0.55434616 |
| 71 | IRAK2 | 0.52339548 |
| 72 | TESK2 | 0.51503939 |
| 73 | SGK2 | 0.50348875 |
| 74 | PLK2 | 0.49464071 |
| 75 | PRKACG | 0.48473668 |
| 76 | MAP2K1 | 0.47952239 |
| 77 | IKBKE | 0.47302213 |
| 78 | SGK3 | 0.46543742 |
| 79 | FER | 0.46261588 |
| 80 | PRKCQ | 0.46219163 |
| 81 | MAP3K1 | 0.44721335 |
| 82 | TRIM28 | 0.44405332 |
| 83 | MAP3K14 | 0.41661373 |
| 84 | NLK | 0.41134143 |
| 85 | PRKCD | 0.40478570 |
| 86 | HIPK2 | 0.38220230 |
| 87 | RAF1 | 0.34989836 |
| 88 | NEK9 | 0.34978251 |
| 89 | MAP3K11 | 0.34339218 |
| 90 | CDC42BPA | 0.34196305 |
| 91 | IRAK3 | 0.34135697 |
| 92 | PRKG1 | 0.33311071 |
| 93 | PIM1 | 0.30800523 |
| 94 | KSR2 | 0.30484583 |
| 95 | SRC | 0.28401878 |
| 96 | PKN1 | 0.27901601 |
| 97 | PRKCB | 0.26262721 |
| 98 | IGF1R | 0.25504300 |
| 99 | KIT | 0.24434029 |
| 100 | CAMK1G | 0.24067922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 4.62182608 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.93141688 |
| 3 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.79255414 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.28713034 |
| 5 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.23441851 |
| 6 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 2.15998923 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.81029889 |
| 8 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.78496687 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75646240 |
| 10 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.69341956 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.62189557 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.61311611 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.60143691 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.55310226 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.48224603 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.47452709 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.47386506 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.45121936 |
| 19 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.38527767 |
| 20 | Gap junction_Homo sapiens_hsa04540 | 1.36634494 |
| 21 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.36579660 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.34859539 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30836758 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.28971464 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.24995083 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24882028 |
| 27 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.22906674 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22802091 |
| 29 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.21689638 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19904602 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.19830042 |
| 32 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.19711097 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18801881 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16527187 |
| 35 | Endocytosis_Homo sapiens_hsa04144 | 1.16163427 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.11148280 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09029890 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08500234 |
| 39 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.05318004 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01927319 |
| 41 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.01569506 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98944809 |
| 43 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.95815398 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.95124723 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94846454 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89866111 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88083103 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84486832 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83934520 |
| 50 | Long-term depression_Homo sapiens_hsa04730 | 0.82726129 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82235548 |
| 52 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81388778 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81108002 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80813982 |
| 55 | Measles_Homo sapiens_hsa05162 | 0.79772894 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79549991 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.79440107 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.78845049 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78349418 |
| 60 | Alcoholism_Homo sapiens_hsa05034 | 0.77890798 |
| 61 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77515688 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73029125 |
| 63 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69943690 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69116205 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 0.67605253 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.66331730 |
| 67 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65848098 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.64586552 |
| 69 | Focal adhesion_Homo sapiens_hsa04510 | 0.63105184 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62694944 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61761117 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60040098 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57683245 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.56666102 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56176022 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.55096398 |
| 77 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54531804 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54252461 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53979912 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.52973694 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52758852 |
| 82 | Morphine addiction_Homo sapiens_hsa05032 | 0.50713719 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48947815 |
| 84 | Circadian entrainment_Homo sapiens_hsa04713 | 0.47306781 |
| 85 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46894950 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46596895 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.44377609 |
| 88 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42870584 |
| 89 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41842363 |
| 90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41837838 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39833421 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39690539 |
| 93 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39279336 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38642107 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.38364844 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.38177649 |
| 97 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37650813 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36646500 |
| 99 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.36307059 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36253318 |

